Text Search: Search by:

Refine your search with filters

Year:

All

Congress Abstracts

Tools & Skills

Publications

Congress Presentations

Videos & Podcasts

Quicksearch

P404: Real-life experience with golimumab in ulcerative colitis patients according to prior anti-TNF useECCO '16 Amsterdam

Year: 2016

Authors:

C. Taxonera*¹, F. Bertoletti², C. Rodriguez³, I. Marin⁴, J. Arribas⁵, P. Martinez-Montiel⁶, M. Sierra⁷, L. Arias⁸, M. Rivero⁹, A. Juan¹⁰, E. Iglesias¹¹, N. Manceñido¹², J.L. Perez-Calle¹³, A. Algaba¹⁴, M. Barreiro-de Acosta¹⁵, A. Gutierrez¹⁶, F. Argüelles¹⁷, D. Busquets¹⁸, M. Chaparro¹⁹, C. Alba¹, D. Olivares¹, M. Calvo²⁰, J.P. Gisbert¹⁹

¹Hospital Clinico San Carlos, IBD Unit, Madrid, Spain, ²Hospital Santa Creu i Sant Pau, Barcelona, Spain, ³Hospital de Navarra A, Department of Gastroenterology, Pamplona, Spain, ⁴Hospital Gregorio Marañón, Madrid, Spain, ⁵Hospital Ramón y Cajal, Department of Gastroenterology, Madrid, Spain, ⁶University Hospital 12 De Octubre, Department of Gastroenterology, Madrid, Spain, ⁷Hospital de León, Gastroenterology, León, Spain, ⁸Hospital de Burgos, Burgos, Spain, ⁹University Hospital Marques de Valdecilla - HUMV, Department of Gastroenterology, Santander, Spain, ¹⁰Hospital Germans Trias i Pujol, Barcelona, Spain, ¹¹Hospital Reina Sofía, Gastroenterology, Córdoba, Spain, ¹²Hospital Infanta Sofía, Gastroenterology, Madrid, Spain, ¹³Hospital Universitario Fundación Alcorcón, Gastroenterology, Madrid, Spain, ¹⁴Hospital de Fuenlabrada, Gastroenterology, Madrid, Spain, ¹⁵Hospital Clínico de Santiago, Gastroenterology, Santiago de Compostela, Spain, ¹⁶Hospital Universitario de Alicante, Alicante, Spain, ¹⁷Hospital Universitario Virgen Macarena, Sevilla, Spain, ¹⁸Hospital Universitari Dr Trueta, Girona, Spain, ¹⁹Hospital La Princesa, IP and CIBERehd, Gastroenterology, Madrid, Spain, ²⁰Hospital Puerta de Hierro, Gastroenterology, Madrid, Spain

P405: Infliximab trough level measured during treatment induction may be predictive of the loss of response to Infliximab during treatment maintenance in inflammatory bowel disease patients: a longitudinal observational retrospective studyECCO '16 Amsterdam

Year: 2016

Authors:

C. Liefferinckx*¹, C. Minsart², A. Cremer¹, L. Amininejad¹, J.-F. Toubeau³, E. Quertinmont², J. Deviere¹, A. Van Gossum¹, D. Franchimont¹

¹Erasme Hospital, Gastro-enterology, Brussels, Belgium, ²Université libre de Bruxelles, Laboratory of Experimental Gastroenterology, Brussels, Belgium, ³Université de Mons, Department of Electrical Engineering, Mons, Belgium

P406: AlphaE+ cells have increased expression of inflammatory markers and are correlated in the ileum and colonECCO '16 Amsterdam

Year: 2016

Authors:

R. Ichikawa¹, J. Eastham-Anderson¹, A. Scherl¹, J. Hackney¹, L. Orozco¹, W. Faubian², J. Mansfield^{3, 4}, J. Kirby³, C. Lamb^{3, 5}, M. Keir*¹

¹Genentech, Inc, a member of the Roche Group, South San Francisco, California, United States, ²Mayo Clinic, Division of Gastroenterology & Hepatology, Rochester, Minnesota, United States, ³Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom, ⁴Institute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom, ⁵Department of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom

P407: Clinical manifestations of thiopurine S-methyltransferase variants in Korean paediatric patients with inflammatory bowel diseaseECCO '16 Amsterdam

Year: 2016

Authors:

M. Kim*

Inje University College of Medicine, Ilsan Paik Hospital, Paediatrics, Goyang-si, Gyeonggi-do, South Korea

P408: Are pharmacokinetics more unfavourable in inflammatory bowel disease patients aged over 60 years?ECCO '16 Amsterdam

Year: 2016

Authors:

L. Rinaldi¹, N. Williet*², E. Del tedesco², c. Jarlot³, J. M. Phelip², s. Paul⁴, X. Roblin³

¹Gastroenterology, Saint Etienne, France, ²CHU Saint Etienne, Saint Etienne, France, ³University Hospital, Gastroenterology, Saint Etienne, France, ⁴University of Saint Etienne, Immunology, Saint Etienne, France

P409: Impact of biological therapy in postoperative morbidity in elective surgical resections in Crohn’s diseaseECCO '16 Amsterdam

Year: 2016

Authors:

P. G. Kotze*¹, M. P. Saab¹, B. Saab¹, L. M. S. Kotze¹, M. Olandoski², L. V. Pinheiro³, C. A. R. Martinez³, M. L. S. Ayrizono³, D. O. Magro³, C. S. R. Coy³

¹Catholic University of Paraná, Colorectal Surgery Unit - Cajuru University Hospital, Curitiba, Brazil, ²Catholic University of Parana, Department of Statistics, Curitiba, Brazil, ³Campinas State University (UNICAMP), Colorectal Surgery department, Campinas, Brazil

P410: Segmental endoscopic scoring improves outcome prediction in acute severe colitisECCO '16 Amsterdam

Year: 2016

Authors:

S. Raimundo Fernandes*, P. Santos, C. Moura, P. Marques da Costa, J. Rita Carvalho, C. Baldaia, A. Valente, A. Rita Gonçalves, P. Moura Santos, L. Correia, J. Velosa

Centro Hospitalar Lisboa Norte, Gastrenterology, Lisbon, Portugal

P411: Four-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patientsECCO '16 Amsterdam

Year: 2016

Authors:

C. Cassieri*¹, R. Pica¹, E. v. V. Avallone¹, G. Brandimarte², M. Zippi¹, P. Crispino¹, G. Lecca², C. Corrado¹, P. Vernia¹, P. Paoluzi¹, E. v. S. Corazziari¹

¹ ‘Sapienza’ University, Internal Medicine and Medical Specialties, Rome, Italy, ²’Cristo Re’ Hospital, Internal Medicine, Rome, Italy

P412: Evolution of patients with ulcerative colitis who withdraw the maintenance treatment with mesalazineECCO '16 Amsterdam

Year: 2016

Authors:

A. Algaba*, I. Guerra, D. Bonillo, M. Hernández, A. Granja, P. Bernal, F. Berrmejo

Hospital Universitario de Fuenlabrada, Gastroenterology, Madrid, Spain

P413: Endoscopic balloon dilatation of Crohn’s strictures is safe and effective in selected casesECCO '16 Amsterdam

Year: 2016

Authors:

A. Asairinachan*, V. An, E. Daniel, M. Johnston, J. Keck, P. Salama, R. Woods

St Vincent’s Hospital Melbourne, Victoria, Australia
Abstract has been withdrawn.

P414: Usefulness of ultrasonography in the assessment of postoperative recurrence of Crohn’s diseaseECCO '16 Amsterdam

Year: 2016

Authors:

M. Murakami*¹, T. Kanemura¹, A. Haga¹, R. Kubota¹, K. Yaguchi¹, M. Nishio¹, S. Tsuda¹, T. Ogashiwa¹, Y. Kogure¹, K. Kasahara¹, K. Hirai², Y. Fukuno², M. Jin², A. Hanzawa², H. Yonezawa², K. Sakamaki³, K. Numata⁴, H. Kimura¹, R. Kunisaki¹

¹Yokohama City University Medical Centre, Inflammatory Bowel Disease Centre, Yokohama, Japan, ²Yokohama City University Medical Centre, Department of Laboratory Medicine and Clinical Investigation, Yokohama, Japan, ³Graduate School of Medicine, Yokohama City University, Department of Biostatistics and Epidemiology, Yokohama, Japan, ⁴Yokohama City University Medical centre, Gastroenterology Centre, Yokohama, Japan

P415: Therapeutic drug monitoring of thiopurines in the management of Asian patients with inflammatory bowel diseaseECCO '16 Amsterdam

Year: 2016

Authors:

S. N. W. Chuah*¹, P. Delord², N. Sutiman³, W. F. Leong³, S. C. Kong¹, B. Schwender¹, P. W. Chan¹, H. H. Shim¹, E. Salazar¹, E. H. Ong⁴, H. Y. Aw⁵, J. L. Hartono⁴, W. C. Lim⁶, C. Ong⁷, P. L. Ong⁸, K. L. Ling¹, B. Chowbay²

¹Singapore General Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore, ²National Cancer Centre, Clinical Pharmacology Laboratory, Singapore, Singapore, ³Singapore Health Services, Clinical Pharmacology, Singapore, Singapore, ⁴National University Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore, ⁵National University Hospital, Division of Paediatric Gastroenterology, Singapore, Singapore, ⁶Tan Tock Seng Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore, ⁷KK Women’s and Children’s Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore, ⁸Changi General Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore

P416: An online educational portal is effective in improving knowledge regarding reproduction and IBDECCO '16 Amsterdam

Year: 2016

Authors:

K. Wierstra¹, K. Smith¹, J. Bal², L. Ambrosio², K. I. Kroeker², L. Dieleman², B. Halloran², R. N. Fedorak², K.-A. Berga³, V. W. Huang*⁴

¹University of Alberta, Edmonton, Canada, ²University of Alberta, Gastroenterology, Edmonton, Canada, ³MacEwan University, Edmonton, Canada, ⁴University of Alberta, Medicine, Edmonton, Canada

P417: Ulcerative colitis: let’s talk about extentECCO '16 Amsterdam

Year: 2016

Authors:

A. Vaz*, M. Eusébio, A. Antunes, P. Queirós, T. Gago, T. Belo, P. Caldeira, H. Guerreiro

Centro Hospitalar do Algarve, Faro, Portugal

P418: Ulcerative colitis and end-stage liver disease in children with primary sclerosing cholangitisECCO '16 Amsterdam

Year: 2016

Authors:

P. Czubkowski*, M. Wozniak, J. Pawlowska, I. Jankowska, J. Kierkus

The Children’s Memorial Health Institute, Department of Gastroenterology, Hepatology, Feeding Disorders and Paediatrics, Warsaw, Poland

P419: Efficacy of vedolizumab in patients with inflammatory bowel disease and failure of anti-TNF-antibodiesECCO '16 Amsterdam

Year: 2016

Authors:

C. Höög*, M. Eberhardson, S. Almer

Karolinska Institute, Stockholm, Sweden

P420: Does vedolizumab change mural vascularisation in ulcerative colitis and is there a correlation with endoscopic findings?ECCO '16 Amsterdam

Year: 2016

Authors:

D. Klett*, D. Strobel, D. Wildner, R. Atreya, M. F. Neurath, R. S. Görtz

Friedrich-Alexander University Erlangen-Nürnberg, Department of Medicine I, Erlangen, Germany

P421: Skin side effects of biologic therapy and systemic drugs in patients with inflammatory bowel diseasesECCO '16 Amsterdam

Year: 2016

Authors:

K. Juzlova¹, K. Koblova¹, J. Herzogova¹, M. Bortlik*², D. Duricova², M. Lukas²

¹2nd Faculty of Medicine, Charles University, Department of Dermatovenereology, Prague, Czech Republic, ²Charles University, IBD Clinical and Research Centre, ISCARE, Prague, Czech Republic

P422: Risks and clinical features of active tuberculosis developed in patients with inflammatory bowel disease receiving anti-tumour necrosis factor therapyECCO '16 Amsterdam

Year: 2016

Authors:

J. W. Lee, C. H. Choi*

Chung-Ang University College of Medicine, Internal Medicine, Seoul, South Korea

P423: Paediatric Crohn’s disease patients with refractory psoriasis treated with a combination of infliximab and ustekinumabECCO '16 Amsterdam

Year: 2016

Authors:

C. Olbjørn*^{1, 2}, J. B. Rove¹, J. Jahnsen^{2, 3}

¹Akershus University Hospital, Department of Paediatric and Adolescent Medicine, Lørenskog, Norway, ²University of Oslo, Institute of Clinical Medicine, Oslo, Norway, ³Akershus University Hospital, Department of Gastroenterology, Lørenskog, Norway